Transforming growth factor-beta is a potent negative regulator of human lymphocytes (Q36401260)

14 August 2017

1 reference

title

Transforming growth factor-beta is a potent negative regulator of human lymphocytes (English)

1 reference

14 August 2017

4

Fauci AS

1 reference

14 August 2017

1

Kehrl JH

1 reference

14 August 2017

Taylor A

2

1 reference

PubMed ID

1648884

14 August 2017

Kim SJ

series ordinal

3

1 reference

PubMed ID

1648884

14 August 2017

language of work or name

English

0 references

publication date

1 January 1991

1 reference

Annals of the New York Academy of Sciences

14 August 2017

1 reference

14 August 2017

628

1 reference

14 August 2017

345-353

1 reference

Purification and initial characterization of a type beta transforming growth factor from human placenta

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB17267.X

Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB17267.X

Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB17267.X

Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB17267.X

Human B cell activation, proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB17267.X

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB17267.X

Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB17267.X

Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB17267.X

The retinoblastoma protein is phosphorylated during specific phases of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB17267.X

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB17267.X

Beta transforming growth factors are potential regulators of B lymphopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB17267.X

Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB17267.X

Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB17267.X

Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB17267.X

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB17267.X

NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB17267.X

10.1111/J.1749-6632.1991.TB17267.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

1648884